Evotec moves business back to UK


German drug discovery company Evotec will close its operations in Thane, India, and move them back to its Abingdon, UK, facility. The move will cost up to €4 million (£3.4 million), and the company’s 120 employees in India will lose their jobs. The firm said it is responding to its European customers’ increasing requirements to operate nearby.

Mario Polywka, Evotec’s chief operating officer, said that the company was due to move its Indian chemistry operations in June 2014. However, ' because of growing customer requirements for European-based activities, we came to the conclusion to exit our operations in India completely’.

Evotec moved into India in 2007, aiming to supply low-cost compound libraries to the pharmaceutical industry. But Polywka was adamant that moving projects back to the UK is a positive step for the company. ‘Through this realignment we will be able to most efficiently serve our customers, utilise our UK chemistry resources… and also realise cost savings.’


Related Content

Business roundup

29 September 2011 Business

news image

Industry news, October 2011

Reaching out

22 May 2014 Premium contentFeature

news image

Andy Extance surveys how pharma uses outsourcing in a variety of different ways

Most Read

Higher levels of some metals in e-cigarette smoke

8 September 2014 Research

news image

Scientists call for regulators to help clear smoke and mirrors surrounding vaping safety

Isotope effect produces new type of chemical bond

22 October 2014 Research

news image

Evidence emerges for vibrational bond first proposed 30 years ago

Most Commented

Higher levels of some metals in e-cigarette smoke

8 September 2014 Research

news image

Scientists call for regulators to help clear smoke and mirrors surrounding vaping safety

Not all science is created equal

16 October 2014 Comments

news image

John Ioannidis explains why researchers should be curious about the differences between disciplines